Saturday, May 30, 2015

Cancer drugs rankings suggest many are of little benefit to patients

Leading experts call on pharmaceutical industry to focus on coming up with meaningful drugs and boost levels of effectiveness

Many modern cancer drugs are of very little benefit to patients, according to a group of leading European experts, who have devised a way to score them.

More and more medicines have been going on to the market with lower and lower levels of benefit

Continue reading...

No comments:

Post a Comment